Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

@article{Hu1996MinibodyAN,
  title={Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.},
  author={Shaojung A Hu and Louise Shively and Andrew A. Raubitschek and Mark E. Sherman and Lawrence E. Williams and Jeffrey Y. C. Wong and John E Shively and Anna M Wu},
  journal={Cancer research},
  year={1996},
  volume={56 13},
  pages={3055-61}
}

• Shaojung A Hu, Louise Shively, +5 authors Anna M Wu
• Published 1996 in Cancer research

A novel engineered antibody fragment (VL-VH-CH3, or "minibody") with bivalent binding to carcinoembryonic antigen (CEA) was produced by genetic fusion of a T84.66 (anti-CEA) single-chain antibody (scFv) to the human IgG1 CH3 domain. Two designs for the connecting peptide were evaluated. In the T84.66/212 LD minibody, a two-amino acid linker (generated by… CONTINUE READING

Save

Watch Paper

Cite

View PDF